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EDITORIAL REVIEW
Diabetic ketoacidosis: Role of the kidney in the acid-base
homeostasis re-evaluated
The development of diabetic ketoacidosis (DKA) involves a
series of closely interrelated derangements of intermediary
metabolism and of body fluid volume and composition whose
fundamental nature has not been completely unraveled [1—81.
The composite clinical picture in full-blown DKA on admission
includes hyperglycemia with hyperosmolality, metabolic acido-
sis due to the accumulation of ketoacids, extracellular and
intracellular fluid (ECF and ICF, respectively) volume deple-
tion, and varying degrees of electrolyte deficiency, particularly
of potassium and phosphate [9—il]. Since proper correction of
the alterations in volume status, acid-base, and electrolyte
composition is critical for survival, a clear understanding of the
pathogenesis of these derangements is essential for the ade-
quate management of DKA. The present review will focus on
the role of the kidney in the pathogenesis of the different
patterns of electrolyte and acid-base composition observed on
admission for and during recovery from DKA. Special empha-
sis will be placed on the role of the kidney in the defense of acid-
base homeostasis during the recovery phase. Other aspects of
the alterations that develop in DKA have been reviewed in
detail elsewhere [12—14].
Insulin deficiency, either absolute or relative, results in
hyperglycemia because of an impairment in glucose oxidation in
most tissues and the excessive hepatic production of glucose. A
derangement in both production and utilization of ketones
represents an additional hallmark in the altered metabolism of
DKA. The major substrates for the production of ketones are
long-chain free fatty acids which are stored in adipose tissue as
triglycerides. Once released from adipocytes, free fatty acids
are transported to the liver, where synthesis of a variety of
lipids occurs. Fatty acids may also be used for the production of
ketones, and since the liver lacks the enzymatic machinery to
further oxidize ketones, these substrates must be exported to
peripheral tissues, such as muscle, brain, and kidney for their
ultimate utilization.
Insulin is currently considered the major regulator of both
production and utilization of ketones by its triple action on
adipose, hepatic, and peripheral tissues [15, 161. In the adipo-
cyte it inhibits lipolysis thus decreasing the release of the
substrate; in the hepatocyte it enhances esterification rather
than oxidation of free fatty acids; and in peripheral tissues it
stimulates the oxidation of ketones. Thus, insulin deficiency
initiates a sequence of metabolic events that results in hyperke-
tonemia due to both overproduction and decreased utilization
of ketones. Ketogenesis is further stimulated by glucagon which
causes an increase in substrate supply and stimulates the
oxidation of fatty acids in the liver. Other counterregulatory
hormones involved in the metabolic derangements of DKA are
catecholamines and cortisol. The net effect of the complex
hormonal imbalance that results is stimulation of gluconeogene-
sis, ketogenesis, and lipolysis, and depression of glycolysis and
glycogenesis.
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Alteration in volume and composition of body fluids
The increase in effective osmotic pressure of the ECF conse-
quent to the elevated glucose level effects a shift of water out of
some cells, most prominently from skeletal muscle. The result-
ing expansion of the ECF compartment is brief due to simulta-
neous renal and extrarenal loss of fluids. The increased filtered
load of glucose, due to hyperglycemia, exceeds the renal
tubular reabsorptive capacity resulting in massive glycosuria
which is a hallmark of DKA [171. During this osmotic diuresis
urinary water losses are disproportionately greater than the
accompanying electrolyte losses, an event which further aggra-
vates the progressive rise in serum osmolality. A special feature
of the osmotic diuresis during DKA is that, in contrast to
mannitol diuresis, the urinary loss of sodium is significantly
greater than that of chloride because most of the urinary anions
are ketones rather than chloride [17, 181. Thus, osmotic diuresis
increases serum sodium and chloride, thereby counterbalancing
the dilution of these electrolytes caused by hyperglycemia. The
migration of sodium to the ICF compartment in replacement of
potassium losses decreases the serum sodium and vomiting may
further magnify chloride losses. The difference in the magnitude
of these losses from one patient to another accounts for the
differences in plasma composition observed on presentation.
The clinical disorder in body fluids composition, however,
results from osmotic diuresis and the urinary loss of ketone
salts of sodium and potassium.
Prerenal azotemia due to volume depletion is a classic finding
in DKA and usually reversible, but occasionally it may progress
to acute tubular necrosis [19—22]. Figure 1 depicts the blood
composition on admission for and after recovery from DKA in a
group of patients we recently evaluated [23]. The levels of urea
nitrogen, creatinine, total proteins, uric acid, hematocrit, and
hemoglobin were all elevated on admission, a reflection of ECF
volume contraction, but they decreased significantly when
water and electrolytes deficit were corrected.
Acid-base changes
During the development of DKA, ketoacids released into the
ECF are titrated by bicarbonate and other body buffers. This
buffering process results in an increase of plasma unmeasured
anions and accounts for the classic pattern of acid-base compo-
sition, namely metabolic acidosis associated with an increased
anion gap (AG) [3, 12, 24—28]. This latter term refers to those
plasma anions, other than chloride and bicarbonate, that bal-
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ance the positive charges of sodium and potassium:
AG = (Nat + K) — (C1 + HC03)
In uncomplicated DKA the increment in AG above its normal
value should be approximately equal to the decrement in
plasma bicarbonate. Thus, the ratio of excess AG to that of
bicarbonate deficit should be about one:
Excess AG
— 1 0Bicarbonate deficit —
where excess AG (mEq/liter) equals measured AG minus
normal AG, and bicarbonate deficit (mEq/liter) equals normal
plasma bicarbonate minus measured plasma bicarbonate.
Table 1 presents admission data obtained andlor calculated
from several published reports of patients presenting with DKA
[6—8, 23, 29—31]. In every study the mean plasma bicarbonate
deficit was approximately equal to the mean excess AG.
However, in apparent contradiction with these results, one
often encounters patients admitted with DKA having severe
metabolic acidosis of the hyperchloremic variety, instead of the
expected AG variety. Evaluation of these patients does not
disclose any specific abnormality in the regulation of acid-base
homeostasis that could lead to hyperchloremic acidosis; com-
plete recovery from metabolic acidosis is observed within a few
days. Values from one such patient are depicted in Figure 2.
Severe metabolic acidosis, accompanied by the appropriate
respiratory response, was present on admission, but the decre-
ment in plasma bicarbonate was associated with an AG within
the normal range (16 4 mEq/liter). A notable additional
feature was that on admission BUN level was within normal
limits, Despite treatment, 60 hr elapsed before the serum total
carbon dioxide rose to 17 mmoles/liter. Serum chloride levels,
although elevated on admission, increased further during the
initial 30 to 36 hr, and were associated with a reciprocal
decrement in the plasma AG. The AG, although not elevated on
admission, progressively fell with treatment due at least in part
to a major reduction in the concentration of plasma proteins
[23]. In this patient the findings and the course of illness are in
contrast to those of patients presenting with pure AG acidosis
illustrated in Figure 3. The plasma bicarbonate deficit on
admission was fully accounted for by the excess AG, as is
expected in typical AG acidosis. In addition there was a
significant impairment of renal function, as indicated by the
increased BUN level on admission. In contrast to the previous
case, recovery from metabolic acidosis was considerably faster.
By hour 16 after admission, total carbon dioxide was 16
mmoles/liter; blood pH was almost normal. Thus, a striking
characteristic of patients presenting with hyperchloremic acido-
sis is a slower recovery from metabolic acidosis when com-
pared to patients presenting with the AG variety.
It should be evident from the foregoing that, for the mean
excess of AG to equal the mean deficit in plasma bicarbonate
(Table 1), there must be patients in whom the excess AG
exceeds the decrement in plasma bicarbonate to average the
patients with hyperchloremic acidosis. To understand these
different acid-base and electrolyte patterns in DKA, the factors
known to alter the stoichiometric relationship between the
increment in AG and the decrement in serum bicarbonate will
be outlined first [23, 27, 321. The ratio of excess AG/bicarbonate
deficit describes this relationship and represents the fraction of
the bicarbonate deficit per liter of plasma that is accounted for
by an increment in the unmeasured plasma anions. A decrement
of the numerator or an increment of the denominator will
decrease the magnitude of the ratio whereas changes in the
opposite direction will increase the value. The mechanisms that
can alter this ratio will be reviewed briefly.
Increase above unity of the ratio of excess AG/bicarbonate
deficit
Any condition that increases plasma bicarbonate, AG, or
both will result in a ratio of excess AG/bicarbonate deficit
greater than one. The most common conditions in which this
situation will be encountered are:
Vomiting or exogenous bicarbonate therapy. Failure of the
measured serum bicarbonate to fall by the amount predicted
from the calculated excess AG has been classically regarded as
the result of a coexisting metabolic alkalosis. Vomiting, which
frequently accompanies the development of DKA, is the most
prominent potential source of a "hidden" metabolic alkalosis.
However, analysis of the electrolyte composition of specimens
of vomitus from patients with DKA revealed that the sodium
concentration actually equalled or exceeded that of the chloride
concentration [3]. Bicarbonate therapy also increases plasma
bicarbonate without altering the AG.
Hyperproteinemia. Alterations in the concentration of pro-
teins may lead to changes in the AG independent of any
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Fig. 1. Laboratory data on admission (left side of each panel) and after
recovery (right side of each panel) from diabetic ketoacidosis. Each
symbol represents an admission. A significant decrease in all parame-
ters from the admission values was observed in the recovery period.
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Table 1. Comparison of admission data in diabetic ketoacidosis
Danowski et a!
(N = 8, [6])
Seldin et al
(N = 10, [7])
Nabarro et al
(N = 7, [8])
Shaw et al
(N = 30, [29])
Assal et al
(N = 9, [30])
Oh et al
(N = 35, [31])
Adrogue et al
(N = 150, [231)
Blood pH 7.06 0.03 7.07 0 7.06 0.01
[Naip, mEq/liter 130 3.2 129 3.7 136 0.5 131 1.4 146 3.0 136 1.6 132 0.6
[K]p, mEqiliter 4.9 0.5 4.7 0.2 5.7 0.2 5.8 0.3 5.6 0.3 5.7 0.1
[Clip, mEqiliter 94 2.8 94 3.5 93 1.0 96 1.3 106 3.0 101 1.4 98 0.6
[HCO3]p, mEqiliter 7.0 0.8 7.4 1.0 7.5 1.1 5.0 0.6a 5.6 1.0 9.6 0.3 6.2 0.2a
Anion gap, mEqiliter 34.3 1.3 32.1 1.5 40.8 2.1 36.7 1.7 40.0 25.0 l.2b 33.5 0.6
[HCO3]p, mEq/literc 17.0 0.8 16.6 1.0 16.5 1.1 22.0 0.6a 18.4 14.4 0.3 20.8 0.2
Anion gap, mEqiliter" 18.3 1.3 16.1 1.5 24.8 2.1 20.7 1.7 24.0 13.0 0.9 17.5 0.6
TCO2 was measured.
b The value was calculated without [K]p.
The values were derived from either 24 mEqlliter or 27 mM/liter depending if [HCO3]p or TCO2 were measured, respectively.
d The values were derived from 16 mEq/liter.
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Fig. 2. Laboratory data on admission and follow-up values during the
hospital course in a patient admitted for diabetic ketoacidosis but
presenting with pure hyperchloremic acidosis. Each symbol represents
a single measurement.
deviation in the plasma bicarbonate [25, 33—35]. Thus, the ECF
volume deficit frequently present in DKA results in hyperpro-
teinemia (Fig. 1), which will be reflected in an increase of
plasma undetermined anions. Also, since a variable degree of
acidemia is present in DKA, the pH-related decrement in the
net negative charge of plasma proteins should be considered.
The net effect of a change in concentration of proteins and the
acidemia-induced decrease in their negative charge will influ-
ence the ratio of excess AG to bicarbonate deficit.
Tissue titration. Titration of intracellular buffers by the
retained ketoacids results in an exchange of cellular sodium and
potassium for extracellular hydrogen ions. The displacement of
sodium to the ECF should result in transfer of water leading to
dilution of all serum electrolytes other than sodium. Madias Ct
al have shown this phenomenon in different types of AG
acidosis [36]. However, their experiments were performed with
an exogenous acid load in nephrectomized animals; therefore,
the applicability of these observations to DKA in humans,
having an endogenous ketoacidemia and a variable level of
renal function, remains to be determined.
A major decrement in systemic pH, due to severe DKA, may
also result in the progressive recruitment of tissue nonbicarbon-
ate buffers, such as some tissue proteins, having a lower pK
[37]. The contribution of these additional buffer systems in the
defense of the acid-base status will lead to a smaller decrement
in plasma bicarbonate for a given increment in plasma unmea-
sured anions.
Renal acid excretion. Prerenal azotemia, that frequently
accompanies DKA, results in an increased AG due to retention
of acids other than ketoacids. In this condition, the plasma
bicarbonate deficit exceeds the level of ketones, but the decre-
ment in bicarbonate remains approximately equal to the incre-
ment in AG, since the retained acids, independent of their
nature, titrate plasma bicarbonate. By contrast, urinary excre-
tion of hydrogen ions with anions other than ketones, promote
the correction of the bicarbonate deficit without altering the
excess anion gap. Since a several-fold increase in net acid
excretion occurs in DKA, this mechanism has the potential for
substantially altering the relationship between AG and bicar-
bonate concentration. The daily renal excretion of hydrogen
ion, as titratable acidity and ammonium, in DKA, has been
shown to attain levels as high as 250 and 500 mEq, respectively
[38].
Selective cellular uptake of hydrogen ions. If the distribution
space of protons includes the ICF compartment, whereas the
distribution space of the anions is limited to the ECF volume,
the decrement in serum bicarbonate would be smaller than the
actual increment in AG. One implication of this assumption is
that, in the recovery phase from DKA, a larger number of
protons than of ketone anions would return to the ECF resulting
in a smaller rise in plasma bicarbonate than the actual decrease
in AG achieved. Oh et al [31] and Oh, Banerji, and Carroll [391
have observed a disparity between the fall in AG and the
increment in serum bicarbonate during the recovery phase of
DKA, which resulted in a hyperchloremic acidosis. They
suggested that a difference in the distribution volume of bicar-
bonate and ketone anions was the most probable explanation
for the observed electrolyte disturbance. This hypothesis, how-
ever, has not been experimentally verified. Moreover, experi-
mental data we have presented strongly suggest a different
mEq/Iiter
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mechanism as the major determinant of the hyperchioremic
acidosis observed in the recovery phase from DKA [231. This is
considered subsequently in the section on the Role of the
kidney.
Decrease below unity of the ratio of excess AG/bicarbonate
deficit
Events which cause a decrement in AG, plasma bicarbonate,
or both will result in a decrease below unity of the ratio of
excess AG/bicarbonate deficit. The major causes responsible
for such a decrease are:
Renal excretion of sodium salts of ketones. Since the renal
threshold for plasma ketones is low and the production of
ketoacids can reach levels as high as 1,000 to 2,000 mEq/day,
the urinary excretion of the sodium salts of the ketoacids may
be enormous [40]. This renal "wasting" of ketone salts will
result in a contraction of the ECF volume which will signal the
kidney to retain dietary or infused sodium chloride. As the
urinary losses of ketones are replaced with chloride, the net
effect will be the development of a hyperchloremic acidosis due
to replacement of the excreted or metabolized ketones with
chloride in the ECF.
Chloride containing infusions. Fifty years ago it was suggest-
ed that saline infusions in the treatment of DKA may result in
the development of hyperchloremic metabolic acidosis [41].
Volume replacement with large quantities of saline infusions is
known to result in dilution of both ketones and bicarbonate;
thus, the AG will decrease due to replacement of an unmea-
sured anion (plasma ketones) with a measured anion (chloride).
Additionally, correction of potassium depletion with the chlo-
ride salt will result in the cellular uptake of potassium in
exchange for ICF hydrogen ions, while most of the chloride will
remain in the ECF. Since the hydrogen ions extruded will be
titrated by extracellular bicarbonate, the net effect will be the
development of hyperchloremic acidosis.
Hypocapnia. Hyperventilation, a classic accompaniment of
DKA, is an adaptive response secondary to metabolic acidosis.
Since the kidney responds in an identical fashion to both
primary and secondary hypocapnia, there should be a suppres-
sion of renal bicarbonate reabsorption [42]. However, the
simultaneous stimulation of renal acidification, as a result of the
coexistent metabolic acidosis, may offest any depression of
bicarbonate reabsorption that might be due to hypocapnia.
Renal tubular acidosis. Two isolated case reports have
suggested the existence of a transient impairment of renal
acidification in the recovery phase of DKA [43, 44]. The
described defect, which seems to involve the distal nephron,
however, appears to be very unusual. On the other hand, the
biochemical derangements that occur in DKA and the renal
disease commonly present in diabetic patients might potentially
alter the renal mechanisms of acidification. Thus, a defect in
proximal acidification may result from severe hypophosphate-
mia commonly encountered in DKA [45]. Other causes of distal
renal tubular acidosis in DKA include interstitial renal disease,
hypoaldosteronism, and hyperkalemia with or without reduced
mineralocorticoid levels.
Differences in the distribution space of hydrogen ions and its
accompanying anions. If the distribution space of the anions
exceeds the ECF volume while that of the protons is restricted
to this compartment, there will be a displacement of chloride
from cells by the entering organic anions, resulting in a decrease
in the ratio of excess AG/bicarbonate deficit. It must be
emphasized however, that any differences in the space of
distribution between the hydrogen ions and its accompanying
ketone anions remains as of yet, purely speculative and based
on unproven assumptions [23].
Since the kidney participates in multiple ways in modulating
the acid-base pattern in DKA, a more detailed evaluation of the
renal function in this condition is in order.
Role of the kidney
The alterations in water and electrolyte composition that
accompany the development of DKA, particularly the ECF
volume deficit, often result in impaired renal function. A
decrease in the renal concentrating ability, as a result of
osmotic diuresis and potassium depletion, will further aggravate
the water depletion [18, 22]. Both GFR and RBF have been
documented to decrease in patients with DKA, with recovery to
normal values in most patients within a few weeks from the
episode [19, 20]. Azotemia, usually considered prerenal, results
from reduced clearance of urea as evidenced by its prompt
correction after repletion of the volume deficit is initiated and a
diuresis is established. Increased urea production from the
enhanced catabolism of amino acids resulting from DKA or due
to any coexistent infectious process might also play some role
in the elevation of BUN levels.
It has been suggested that the development of renal disease
results in an improvement in the course of diabetes mellitus; for
decades clinicians have been aware that glycosuria in diabetic
patients frequently disappears once kidney disease is estab-
lished [46]. About 30 years ago, Zubrod, Eversole, and Dana
Glucose
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Fig. 3. Laboratory data on admission and follow-up values during the
hospital course in a patient admitted for diabetic ketoacidosis present-
ing with pure anion gap acidosis. Each symbol represents a single
measurement.
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Fig. 4. Comparison of laboratory data on admission for diabetic
ketoacidosis in patients presenting with hyperchioremic acidosis (left
side of each panel) and those presenting with anion gap acidosis (right
side of each panel). Patients were classified by their type of acidosis-
hyperchloremic or anion gap, according to the excess anion gap/bicar-
bonate deficit ratio values. Hyperchioremic acidosis was arbitrarily
defined to exist when the excess anion gap/bicarbonate deficit ratio was
below 80%. Each bar depicts mean values 1 SE.
[461 described an amelioration of diabetes, as manifested by a
lesser insulin requirement, and the rarity of metabolic acidosis
in patients having developed the renal lesion of Kimmelstiel-
Wilson. The observation that DKA was uncommon in patients
with the clinical syndrome of Kimmeistiel-Wilson was subse-
quently confirmed by other investigators [47, 48]. It is currently
well established that insulin requirements commonly decrease
with the progression of renal failure in patients with diabetic
glomerulosclerosis. Diminished carbohydrate intake due to
anorexia, decreased renal gluconeogenesis as a result of a
reduced functioning nephron mass, and prolonged insulin half-
life due to reduced renal catabolism are some of the factors
responsible for the reduction in insulin requirements [49, 50].
Until recently, the role of the kidney as a major factor in the
pathogenesis of the variable acid-base and electrolyte pattern in
DKA was unrecognized [23J. It has been long established,
however, that impairment of renal function in the course of
DKA might lead to more severe hyperglycemia and hyperosmo-
lality as a result of a marked decrement in the urinary excretion
of glucose [7, 51]. Recently, we have demonstrated that on
admission for DKA, some patients had pure AG acidosis,
others had pure hyperchloremic acidosis, and the rest a combi-
nation of both disturbances. However, when the data was
analyzed as a group, the results obtained were consistent with
the classic pattern of AG acidosis in all the patients (Table 1).
The overall level of renal function on admission was found to be
the major determinant of the type of metabolic acidosis. Labo-
ratory data indicative of the status of the ECF volume were
compared in patients who on admission had mainly "AG
acidosis" to those of patients who had mainly "hyperchloremic
acidosis." As depicted in Figure 4, the mean values of BUN,
serum creatinine, plasma proteins, uric acid, and hematocrit
and hemoglobin values were all lower in patients with "hy-
perchloremic acidosis" than in those with "AG acidosis."
These results indicate that the severity of ECF volume deficit is
greater in patients presenting with AG acidosis as compared to
those with hyperchloremic acidosis. These findings were taken
to mean that patients with DKA who develop significant
volume depletion, as a result of osmotic diuresis and vomiting,
will present with the classic AG type of metabolic acidosis
because of a reduced excretion of ketone salts consequent to
volume depletion. Conversely, patients with DKA who are able
to maintain salt and water intake, thus preventing the develop-
ment of volume depletion, will present with variable degrees of
hyperchloremic acidosis, due to the urinary excretion of ketone
salts and a concomitant retention of chloride. Strong support
for this hypothesis was obtained from a group of balance
studies, which demonstrated that the retention of chloride in
excess of sodium, associated with urinary excretion of ketones
of a magnitude comparable to that of retained chloride, fully
explained the development of hyperchloremic acidosis in the
early period after admission [23]. A similar mechanism could
account for the development of hyperchloremic acidosis prior
to admission.
Considering that in DKA the patient is unable to properly
metabolize ketoacids, whether their salts are retained in the
ECF or are lost in the urine as sodium and/or potassium salts,
theoretically should not have any major effect on the severity of
the acid-base disorder. The data gathered confirmed this predic-
tion because no difference in the severity of the hypobicarbona-
temia was found between the two forms of metabolic acidosis at
the time of admission [23]. One may wonder why hyperchlore-
mic acidosis is repeatedly recognized only in the recovery
phase of DKA but not at the time of admission. Since the
accepted treatment of DKA involves the administration of
rather large amounts of saline infusions, most patients develop
obvious hyperchloremic acidosis in the early period after ad-
mission. By contrast, the magnitude of the hyperchloremic
acidosis before admission is smaller making its recognition less
likely. Furthermore, unless the ratio of excess in AG to that of
bicarbonate deficit is evaluated in each patient on admission for
DKA, a large number of patients having only a component of
hyperchloremic acidosis will go unrecognized. Finally, previ-
ous studies have evaluated the relationship between the excess
AG and the bicarbonate deficit on admission by comparing the
mean values of both parameters, so that individual variations in
the excess AG/bicarbonate deficit ratio were, by necessity,
hidden.
The hyperchloremic acidosis observed in DKA is usually
brief, and it is considered to have no adverse clinical conse-
quence [52]. Since the development of this variety of acidosis
results from the renal loss of bicarbonate precursors (ketone
salts other than ammonium) accompanied by the retention of
Hct Hb
Hyperchloremic Anion gap
acidosis acidosis
Hyperchioremic Anion gap
acidosis acidosis
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chloride, these patients should theoretically have a slower rate
of recovery from the acid-base disturbance. Indeed, prospec-
tive studies have demonstrated that patients admitted with a
greater component of hyperchloremic acidosis had, at any given
time after admission, a smaller increment in their plasma
bicarbonate above their admission levels [23]. It appears that
the more rapid recovery from metabolic acidosis in patients
with DKA presenting with AG acidosis is consequent to the
equimolar conversion of the retained ketone salts to bicarbon-
ate after insulin administration. It might then be postulated that
in patients with severe renal insufficiency who develop DKA,
the underlying reduction in renal function will assure the
retention of bicarbonate precursors, thus the acid-base distur-
bance will be rapidly reversed once insulin is provided. Where-
as, to our knowledge, data in support of such a notion are not
currently available, in the few instances we have had the
opportunity to observe severe DKA in subjects with reduced
renal function, the recovery from the acid-base disturbance was
notably fast.
The capacity of renal acidification under normal conditions is
such that the excretion of fixed metabolic acids is accomplished
without the development of sodium and/or potassium depletion.
On the other hand, in DKA the excessive production of
metabolic acids overwhelms the renal mechanisms of acidifica-
tion and a progressive acidosis occurs accompanied by major
urinary losses of sodium and potassium. It should be recalled
that a voltage-dependent stimulus for proton secretion occurs in
the distal nephron when sodium is absorbed without an accom-
panying anion. A significant electrical gradient favoring distal
hydrogen ion secretion is expected to be present in DKA as a
result of the increased distal sodium delivery (ketonuria and
osmotic diuresis), avid sodium absorption (ECF volume con-
traction), and the presence of nonabsorbable anions (ketones).
However, failure of the kidney to compensate for the acid load
is the result of the high rate of delivery to the distal nephron and
the physicochemical properties of ketoacids [381. It has been
long recognized that the larger the renal excretion of betahy-
droxybutyrate the greater is the deviation from the theoretical
maximum rate of acid excretion, therefore increasing the frac-
tion that is excreted in the urine as sodium or potassium salts
[53, 54]. The low renal threshold of ketoacids results in signifi-
cant urinary excretion of ketones at plasma concentrations only
slightly above normal [55, 561. In addition, betahydroxybutyric
and acetoacetic acids are relatively strong acids (PKa of 4.70
and 3.58, respectively) so that at the urine pH found in patients
with DKA, they are excreted to a significant extent as sodium
and potassium salts, which represents a loss of bicarbonate
precursors. In fact, from studies in experimental ketoacidosis,
it was concluded that despite maximal stimulation of urinary
acidification, the efficiency of the kidney to restore the cation of
the ketone salts to the blood is such that, for each millimole of
betahydroxybutiric acid excreted, the kidney could salvage
only about half a milliequivalent of potential base [5]. Although
ketones have been shown to inhibit the rate of renal ammonia-
genesis in the experimental animal [57, 58], this effect most
probably plays only a minor role in humans, since a sizable
increment in urinary ammonium excretion is present in DKA
[38]. A reduction in the renal excretion of ammonia may be
present as a result of functional (that is, hyperkalemia, hypoal-
dosteronism) or anatomical (that is, interstitial nephritis) distur-
Table 2. Role of the kidney in the acid-base defense in physiological
conditions and during recovery from diabetic ketoacidosisa
Post-
admission
Physiological
conditionsb
TA + NH4 - HCO
Diabetic ketoacidosis
TA + NH4 - HCO
Balance Cum balance
mEq
Balance Cum balance
mEq
0 to 4 hr
4 to 8 hr
8 to 12 hr
12 to 16 hr
16 to 20 hr
20 to 24 hr
12.7 12.7
12.7 25.4
12.7 38.1
12.7 50.8
12.7 63.5
12.7 76.2
—45.0 8.2 —45.0 8.2
—10.3 13.5 —55.3 20.8
1.8 6.8 —53.5 27.1
16.5 2.0 —37.0 28.3
14.3 2.3 —22.7 28.9
21,2 4.8 —1.5 31.2
a The values presented are means 1 s of four studies.
b The values are estimated according to the mean body weight of the
diabetic patients (61 kg) and considering the normal net acid excretion
equal to 1.25 mEq/kg body weight/day.
Actual plus potential bicarbonate is shown; ketone salts other than
ammonium represent potential bicarbonate.
bances. The association of hyperchloremic metabolic acidosis,
hyporeninemia, hypoaldosteronism, and hyperkalemia has
been repeatedly documented in diabetic patients and is current-
ly known as type IV renal tubular acidosis [59—62].
Balance studies carried out in the early period after admission
revealed that correction of volume depletion resulted in mas-
sive urinary loss of bicarbonate precursors that exceeded the
elevated levels of urinary titratable acidity and ammonium
(Table 2). The urinary loss of the sodium and potassium salts of
ketone anions precludes their conversion to bicarbonate when
insulin is administered. Thus, in the initial period after admis-
sion the kidneys of patients with DKA having a typical AG
acidosis behave in a maladaptive fashion relevant to the system-
ic acid-base composition. Only, when the plasma ketones have
fallen substantially, is stimulation of urinary excretion of titrat-
able acidity and ammonia responsible for the initiation of the so-
called renal compensation of DKA.
Concluding remarks
The interaction of multiple factors during the development of
and recovery from DKA is responsible for the wide variation in
the acid-base and electrolyte pattern encountered in this disor-
der. Most prominent among these factors are: the primary
derangements in the electrolyte composition as a result of the
acute acid-base stress, the regulatory defense mechanisms of
renal and extra-renal origin, and the therapeutic interventions.
As a consequence, although theoretically DKA is a typical AG
acidosis, careful evaluation of the laboratory data in individual
patients presenting with this disorder demonstrates a complete
spectrum of values that ranges from pure AG acidosis to pure
hyperchloremic acidosis. A number of the mechanisms that
may alter the relationship between the excess plasma AG and
plasma bicarbonate deficit in these patients have been outlined.
However, it appears that only some of them play a major role as
determinants of the serum electrolyte pattern. Differences in
the supply of water and electrolytes during the development of
DKA, by virtue of their effects on renal function, seem to be
among the most prominent factors that modulate the ECF level
of plasma ketones. The more severe the volume depletion, the
greater is the degree of impairment of the renal function and
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retention of ketones, and the less prominent the component of
hyperchloremic acidosis, The development of hyperchloremic
acidosis in the course of DKA appears to be the result of
chloride retention in excess of sodium associated with signifi-
cant urinary losses of ketone salts of sodium and potassium. Re-
evaluation of the role of the kidney in the development of and
recovery from DKA indicates that maximal stimulation of renal
acidification may not suffice to compensate for the massive
urinary loss of bicarbonate precursors in the form of ketone
salts other than ammonium. Therefore, the end result may be a
nonhemostatic role for the kidney in the defense of the acid-
base equilibrium in the early phase of DKA.
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